Browse EX-10 agreements

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT

This Amendment No. 2 to Employment Agreement (this “Amendment”) is entered into on August 27, 2026 between Hycroft Mining Holding Corporation (“Employer”) and Rebecca A. Jennings (“Employee”).

WHEREAS, Employer and Employee previously entered into an Employment Agreement, dated May 29, 2024, and an Amendment No. 1 to Employment Agreement, dated March 3, 2025 (collectively, the “Employment Agreement”); and

WHEREAS, the Company and Executive desire to amend the Employment Agreement to reflect the certain changes related to Employee’s promotion.

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows, in each case effective as of August 27, 2026:

…

Amendment No. 1 to Amended And Restated Employment Agreement

This Amendment No. 1 to Amended and Restated Employment Agreement (this “Amendment”) is entered into as of August 25, 2026, by and between BRC Group Holdings, Inc., f/k/a B. Riley Financial, Inc. (the “Company”) and Bryant R. Riley (the “Executive”). The above parties are referred to collectively herein as the “Parties,” and individually as a “Party.”

RECITALS

** **

WHEREAS, the Parties have entered into an Amended and Restated Employment Agreement dated as of November 8, 2025, a copy of which is publicly filed (the “Existing Agreement”); and

** **

WHEREAS, the Company and the Executive desire to amend the Existing Agreement to revise certain terms relating to the amount of severance due to Executive upon termination of the Executive under certain circumstances.

AGREEMENT

** **

…

WILLIAMS-SONOMA, INC.

DIRECTOR COMPENSATION POLICY

(Adopted and approved on June 2, 2021 and amended on May 29, 2024, June 11, 2025, and June 18, 2026)

Each member of the Board of Directors (the “Board”) of Williams-Sonoma, Inc. (the “Company”), who is not an employee of the Company (each such member, a “Non-Employee Director”), will receive the compensation described in this Director Compensation Policy (the “Director Compensation Policy”) for his or her Board service following the date set forth above (the “Effective Date”).

The Director Compensation Policy will become effective upon the Effective Date. The Director Compensation Policy may be amended at any time in the sole discretion of the Board.

Annual Cash Compensation

…

3250 Van Ness Avenue

San Francisco, CA 94109

(415) 616-8698

Monica Bhargava

[***]

Re:    Separation Agreement and General Release

Dear Monica:

This Separation Agreement and General Release (the “Agreement”) is a contract that confirms the agreement between you and Williams-Sonoma, Inc. (“WSI” or the “Company”) regarding your separation of employment from the Company.

1.Separation. Your separation date with the Company is May 21, 2026 (the “Separation Date”).

2.Severance. As consideration for your timely execution and non-revocation of this Agreement, including its general release of claims, and provided you comply with the terms and conditions of this Agreement, the Company will provide you with the following:

a.Severance Pay. The Company will pay you a total sum of $900,000.00 (which is equivalent to one year of your base pay), less applicable withholdings and deductions, within 30 days of the Effective Date.

…

August 25, 2026

GEOVAX LABS, INC.

Holder of Common Stock Purchase Warrants

Re: Inducement Offer to Exercise Common Stock Purchase Warrants

Dear Holder:

GeoVax Labs, Inc., a Delaware corporation (the “Company”), is pleased to offer to you (the “Holder”) the opportunity to exercise all of the Common Stock Purchase Warrants issued to you on February 17, 2026 (with a current exercise price of $2.31 per share) (the “February I 2026 Warrants”), February 17, 2026 (with a current exercise price of $2.31 per share) (the “February II 2026 Warrants”), March 31, 2026 (with a current exercise price of $1.36 per share) (the “March 2026 Warrants”), May 8, 2026 (with a current exercise price of $1.65 per share) (the “May 2026 Warrants”), May 19, 2026 (with a current exercise price of $1.48 per share) (the “May 19 I 2026 Warrants”), and May 19, 2026 (with a current exercise price of $1.48 per share) (the “May 19 II 2026 Warrants” and, collectively with the February I 2026 Warrants, February II 2026 Warrants, March 2026 Warrants, May 2026 Warrants, May 19 I 2026 Warrants and

…

CONSULTING SERVICES AGREEMENT Between Darren Yeates of 62 Gilgandra Street, Indooroopilly in the State of Queensland (Executive) And Peabody Energy Australia Coal Pty Ltd (ABN 61 001 401 663) of Level 14/31 Duncan St, Fortitude Valley in the State of Queensland (Company) And Peabody Energy Corporation, a Delaware corporation (Peabody) 1. Consulting Period. Effective from 1 February 2027 ("Consulting Start Date") and ending on 31 January 2028 ("Consulting End Date"), unless terminated earlier as provided herein or extended by mutual agreement in writing (such period, the "Consulting Period"), Executive shall provide general consulting services under this agreement. 2. Services. Executive will provide services as a 'Consultant' to the Company and Peabody at the request of either party. The Executive's services will be at the direction of and reporting to the then-current Chief Executive Officer, President, and/or Chief Operating Officer of Peabody. 3. Time Commitment. Executive must provide consulting services to the Company and/or Peabody under this Agreement for up to a total of 40 h

…

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made as of the 4thday of November, 2024, by and between STRATTEC SECURITY CORPORATION, a Wisconsin corporation (the “Company”), and Chey Becker - Varto (the “Employee”).

RECITAL

The Company desires to employ the Employee and the Employee is willing to make the Employee’s services available to the Company on the terms and conditions set forth below.

AGREEMENTS

In consideration of the premises and the mutual agreements which follow, the parties agree as follows:

1.

Employment. The Company hereby employs the Employee and the Employee hereby accepts employment with the Company on the terms and conditions set forth in this Agreement.

2.

…

Execution Version

AMENDMENT NO. 14 to RECEIVABLES PURCHASE AGREEMENT and
AMENDMENT NO. 2 TO PERFORMANCE UNDERTAKING

= = =

THIS AMENDMENT NO. 14 TO RECEIVABLES PURCHASE AGREEMENT and
AMENDMENT NO. 2 TOPERFORMANCE UNDERTAKING(this “Amendment”), dated as of August 25, 2026 (the “Effective Date”), is entered into by and among:

(1) SUPERIOR COMMERCE LLC, a Delaware limited liability company (the “Seller”),

(2) SCP DISTRIBUTORS LLC, a Delaware limited liability company, as the “Servicer”),

(3) POOL CORPORATION, a Delaware corporation, as the “Performance Guarantor”,

(4) PNC BANK, NATIONAL ASSOCIATION (“PNC”or a “Purchaser”),

(5) REGIONS BANK (“Regions”or a “Purchaser”),

(6) WELLS FARGO BANK, NATIONAL ASSOCIATION, individually (“Wells” or a “Purchaser”, and together with Regions and PNC, the “Purchasers”); and

(7) WELLS FARGO BANK, NATIONAL ASSOCIATION, as administrative agent for the Purchasers (in such capacity, the “Administrative Agent”).

PRELIMINARY STATEMENT

…

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is made and entered into effective as of  *                *, 2025, among Adaptin Bio, Inc., a Delaware corporation (f.k.a. Unite Acquisition 1 Corp.) (the “Company”), the persons who have purchased the Units (as defined below) and have executed omnibus or counterpart signature page(s) hereto (each, a “Purchaser” and collectively, the “Purchasers”), the persons or entities identified on Schedule 1 hereto holding Pre-Merger Warrants (as defined below), the persons or entities identified on Schedule 2 hereto holding Note Conversion Shares (as defined below), the persons or entities identified on Schedule 3 hereto holding Registrable Pre-Merger Shares (as defined below), and the persons or entities identified on Schedule 4 hereto holding Placement Agent Warrants (collectively, the “Brokers”). Capitalized terms used herein shall have the meanings ascribed to them in Section 1 below or in the Subscription Agreement (as defined below).

** **

RECITALS:

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH “[*].”

** **

PATENT LICENSE AGREEMENT

This Patent License Agreement (this “Agreement) is effective as of January 11, 2023 (the “EFFECTIVE DATE”), between Centaur Bio, Inc. (“LICENSEE”) having the address in Article 12 below, and Duke University, a nonprofit educational and research institution organized under the laws of North Carolina (“DUKE”). LICENSEE and DUKE hereby agree as follows:

…

EXECUTIVE EMPLOYMENT AGREEMENT

This Executive Employment Agreement (this “Agreement”) is entered into as of February 11, 2025, by and between Adaptin Bio, Inc. (f/k/a Unite Acquisition 1 Corp.), a Delaware corporation (the “Company”), and Michael J. Roberts (the “Executive”).

WHEREAS, in connection with, and conditioned upon the completion of, the merger (the “Merger”) between the wholly-owned subsidiary of Unite Acquisition 1 Corp. and private company Adaptin Bio, Inc. (“Adaptin”), the Company wishes to employ Executive as its President and Chief Executive Officer, and Executive wishes to accept such employment, on the terms set forth in this Agreement;

WHEREAS Executive acknowledges and agrees that through Executive’s association with Adaptin as an employee, Executive will acquire a considerable amount of knowledge and goodwill with respect to the business of the Company, which knowledge and goodwill are highly valuable to the Company and which would be detrimental to the Company if used by Executive to compete with the Company; and

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH “[*].”

SPONSORED RESEARCH AGREEMENT

This sponsored research agreement (“Agreement”) is effective August 8, 2024 (“Effective Date”) and is between Duke University, a tax-exempt research and educational institution located in Durham, North Carolina, acting for and on behalf of its School of Medicine (“Duke”), and Centaur Bio a corporation with offices at 7805 Pemswood Street, Charlotte, NC 28277 (“Sponsor”). The parties represented in this Agreement shall be referred to individually as a “Party” and collectively as the “Parties”.

WHEREAS, the research contemplated by this Agreement is of mutual interest and benefit to Duke and Sponsor, and will further the instructional and research objectives of Duke in a manner consistent with its status as a non-profit research and educational institution.

…